The associations of obesity, lymph node status and prognosis in breast cancer patients: Dependence on estrogen and progesterone receptor status

$48.00 plus tax (Refund Policy)

Download / Buy Article:

Abstract:

Maehle BO, Tretli S, Thorsen T. The associations of obesity, lymph node status and prognosis in breast cancer patients: Dependence on estrogen and progesterone receptor status. APMIS 2004;112:349–57.

Breast cancer patients who are obese have a higher risk of lymph node metastases and a poorer prognosis than those who are slim. It has been claimed that estrogens derived from fat are important for these associations. If estrogens are important, these relationships must be stronger in the hormone receptor-positive than in the hormone receptor-negative groups. Body mass index (BMI) was used as a measure of obesity. The second, third, and fourth quintiles of BMI were treated as one group and termed ‘medium’. Patients in the fifth quintile were termed ‘obese’ and those in the first quintile ‘slim’. The number of women with unilateral disease treated with modified radical mastectomy and included in the study was 1211. Of all patients included, obese patients had a 1.53 higher risk of lymph node metastases compared to slim patients (p=0.02). In the PgR-negative group, obesity gave a 3.08 times higher risk of lymph node metastases (p=0.03). The risk of dying of breast cancer tended to be higher in obese than in slim patients when all patients in the study were compared (relative risk=1.38, p=0.06). BMI did not show a statistically significant relationship with prognosis if only hormone receptor status was considered. However, if lymph node status and hormone receptor status were taken together, the association was strong and reversed in the lymph node-positive group with ER-negative tumours. The adjusted relative risk was 0.33, showing that slim patients had a 3.03 (1.0/0.33) times higher risk of dying of breast cancer compared to obese patients (p=0.002). These results indicate that non-hormonal mechanisms could be important.

Keywords: Breast cancer; body mass index; estrogen receptor; lymph node status; progesterone receptor; prognosis

Document Type: Research Article

DOI: http://dx.doi.org/10.1111/j.1600-0463.2004.apm1120605.x

Affiliations: 1: The Cancer Registry of Norway, Institute of Epidemiological Cancer Research, Montebello, Norway 2: The Hormone Laboratory Haukeland University Hospital, Bergen,

Publication date: June 1, 2004

Related content

Tools

Favourites

Share Content

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more